Registry to track use of high-risk medical devices soon

NEW DELHI: Taking cue from the Johnson & Johnson faulty hip implants case which left patients in India in physical and financial distress, the health ministry is planning an independent registry to track use of medical devices considered to have a higher risk of complications or complaints.

Once the registry is in place, hospitals and doctors conducting surgeries involving high-end medical devices like orthopedic implants and stents will have to mandatorily report data related to the implant and its manufacturer along with side-effects and any adverse events reported by patients post-surgery.

If a significant number of concerns are reported with regard to a particular product, the regulator will evaluate the data and even order an immediate recall of the product if required. In case the effects are not very severe, the regulator can issue an alert or a warning on usage. These warnings can be on product packages or even in the form of advisories to hospitals and doctors.

The move follows recommendations of a government committee, under former dean of Maulana Azad Medical College Dr Arun K Agarwal, which examined complaints regarding replacement surgeries using the J&J hip implants. “Provisions may be introduced under the law for a legal backing for issuing alerts and warnings to the manufacturer,” the committee said in its report.

“This will not only help save many patients from suffering adverse fallouts but also help in providing a trend analysis of performance of various medical devices in India annually,” a senior official told TOI.

Such registeries are in place in most developed countries like US, European nations, Australia and Japan and have often helped regulators raise an alarm in case of faulty products without waiting for the manufacturer to withdraw the device or take action. In most countries, such registries are maintained by specialist associations while in others the drug regulator, government or research agencies are involved. There is no such mechanism in place for medical devices in India. “There is no authentic data on number of implants used or replacement surgeries conducted,” the official said.

  • Related Posts

    Yashoda Medicity lifts Benchmark in Critical Care to New High

    With the introduction of North India’s first Advanced VitalGo Total Lift Bed Technology Ghaziabad/ New Delhi: In an ideal hospital, critical care is most paramount and it is also the…

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    Healthy Heart is a Misnomer until underpinned by Regular Screening Bangaluru/ New Delhi: Of late, heart health has become kind of a veritable conundrum. We were never so unsure of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

    FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

    Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

    Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

    FSSAI Issues Prohibition Orders against FOLINEURO Syrup and Neuherbs TRUE VITAMIN over Misleading Claims

    FSSAI Issues Prohibition Orders against FOLINEURO Syrup and Neuherbs TRUE VITAMIN over Misleading Claims

    Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

    Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

    Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

    Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

    13 Years after Oxytocin Order, HC Seeks Compilance Status

    13 Years after Oxytocin Order, HC Seeks Compilance Status